New fields in biology, such as molecular genetics, metabolomics, and bioinformatics, empower and guide our designs for new hemp/cannabis strains. We can then use various genetic engineering techniques, such as DNA sequencing, molecular breeding, and gene/genome editing, to create the changes we desire. These modern techniques allow us to determine the specific DNA coding sequences that hemp/cannabis uses to produce cannabinoids or terpenes of interest, to edit these sequences in a precise manner, and to quickly measure the results of these changes. For example, we can now manipulate hemp/cannabis to increase levels of therapeutic cannabinoids (such as cannabidiol) or modulate the relative amounts of volatile fragrant terpenes to suit consumer preferences.
GVB has optimized phytocannabinoid production from seed to shelf. They offer scalable production, extraction, and packaging of valuable cannabinoids for bulk and specialty markets. GVB hemp/cannabis research is centered on developing strains with enhanced agronomics and disease/pest resistance that can be grown indoors and out. We have been able to develop hemp with elevated CBD, along with negligible THC. GVB’s R&D collaborations enhance these efforts by accelerating conventional breeding, introducing new breeding techniques (such as gene editing and molecular breeding), and employing human cell-based assay systems to help define cannabinoid potency.